Top Woman Innovator in Biotechnology Industry

Dr. Gupte has over 25 years of academic and pharmaceutical experience in novel molecular target and drug discoveries that have led to the development of unique anti-breast cancer therapies and diagnostics. She received her M.S. in Microbiology & Immunology, University of Bombay, India and worked as a Senior Scientific Officer in Neo-Pharma, Bombay, India. She received her Ph.D. in Biochemistry & Molecular Biology, New York Medical College and was a Research Associate in the Department of Physiology. She was appointed as an Assistant Professor at the University of South Alabama, Department of Biochemistry & Molecular Biology, and currently is a Visiting Scientist, Department of Pharmacology at New York Medical College. Her expertise in breast cancer research and pharmaceutical background uniquely blended her knowledge of both worlds, empowering her to launch Raadysan Biotech, Inc., with the mission of developing and commercializing revolutionary therapies and diagnostics for Triple Negative Breast. Her company identified a unique molecular biomarker for breast cancer; developed proprietary RNAi therapies; identified and developed Small Molecule Inhibitors for the treatment of Triple Negative Breast Cancer. They are also developing companion diagnostics for the diagnosis of Triple Negative Breast Cancer. Her scientific research highlights Includes - identifying signaling pathways of a DNA replication protein in mitosis and cytokinesis in cancer cells and has developed several unique cytology techniques for DNA-FISH with a unique DNA-FISH probe in breast cancer tissue microarrays, that was distributed to Medical Genetics, Department of Pathology, USA, and University of Pennsylvania for clinical applications. She has published over 21 abstracts and 23 full-length publications in scientific journals. Over the course of 25 years, Dr. Gupte has received numerous honors and awards for her scholastic achievements. She has supervised and trained numerous students and post-doctoral fellows in lab facilities as well as conducted lectures at New York Medical College and University of South Alabama. She received four intramural grants from University of South Alabama and was a Co-IP on an NIH grant. She is currently a Co-I on 2 other NIH grants. She holds 5 US issued patents and one PCT.